Severe Alpha 1 Antitrypsin Deficiency Aatd clinical trials

Explore recruiting severe alpha 1 antitrypsin deficiency aatd clinical trials.

Recruiting severe alpha 1 antitrypsin deficiency aatd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Severe Alpha 1 Antitrypsin Deficiency Aatd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Safety and clinical parameter assessment of a 12-week home self-infusion therapy with Prolastin® in patients with severe alpha-1-antitrypsin (AATD) deficiency. The “Sunshine Study”

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Severe Alpha 1 Antitrypsin Deficiency Aatd trials by city

Severe Alpha 1 Antitrypsin Deficiency Aatd in Toronto Severe Alpha 1 Antitrypsin Deficiency Aatd in Vancouver Severe Alpha 1 Antitrypsin Deficiency Aatd in Montreal Severe Alpha 1 Antitrypsin Deficiency Aatd in Calgary Severe Alpha 1 Antitrypsin Deficiency Aatd in Edmonton Severe Alpha 1 Antitrypsin Deficiency Aatd in Ottawa Severe Alpha 1 Antitrypsin Deficiency Aatd in Winnipeg Severe Alpha 1 Antitrypsin Deficiency Aatd in Quebec City Severe Alpha 1 Antitrypsin Deficiency Aatd in Hamilton Severe Alpha 1 Antitrypsin Deficiency Aatd in Kitchener Severe Alpha 1 Antitrypsin Deficiency Aatd in London Severe Alpha 1 Antitrypsin Deficiency Aatd in Halifax Severe Alpha 1 Antitrypsin Deficiency Aatd in New York Severe Alpha 1 Antitrypsin Deficiency Aatd in Los Angeles Severe Alpha 1 Antitrypsin Deficiency Aatd in Chicago Severe Alpha 1 Antitrypsin Deficiency Aatd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease